申请人:Landry Donald
公开号:US20130053343A1
公开(公告)日:2013-02-28
Compounds having the structures below that are TPH1 inhibitors are provided: The compounds are useful of, e.g., to increase bone mass. In preferred embodiments, the patient is known to have, or to be at risk for, a low bone mass disease such as osteoporosis.